Arturo Reyes-Sandoval – University of Oxford, UK
P. vivax is the most widespread malaria parasite. A vaccine would be a major tool to contribute to its elimination. The pre-erythrocytic stages are an attractive target for vaccine development but many hurdles make such developments difficult to achieve. Approaches to develop a vaccine and assess its efficacy will be presented and discussed.